Treating postoperative pain in the patient who is in recovery or remission from opioid abuse: Focus on Tapentadol

Robert L. Barkin, MBA, PharmD, FCP, DAAPM, DACFE, DACPS; Stacy J. Barkin, BA, MA, MEd, PsyD

doi:10.5055/jom.2017.0378

Authors

Robert L. Barkin, MBA, PharmD, FCP, DAAPM, DACFE, DACPS
Stacy J. Barkin, BA, MA, MEd, PsyD

DOI:

https://doi.org/10.5055/jom.2017.0378

Keywords:

postoperative pain, recovery, tapentadol

Abstract

No abstract

Author Biographies

Robert L. Barkin, MBA, PharmD, FCP, DAAPM, DACFE, DACPS

Professor, Anesthesiology, Family Medicine, Pharmacology, Rush University Medical College, Chicago; Clinical Pharmacologist ,NorthShore University HealthSystem, Department of Anesthesiology, Pain Centers of Skokie and Evanston Hospital, Illinois

Stacy J. Barkin, BA, MA, MEd, PsyD

Clinical Psychologist in Health Psychology and Chemical Dependency–DACFM, DACFE, Scottsdale, Arizona

References

Manchikantl M, Kaye AM, Knezevic NN, et al.: Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician. 2017; 20(2S): S3-S92.

Barkin RL: Pharmacist’s Evolving Role in the Nonopioid, Over-the-Counter, Analgesic Selection Process. Am J Ther. 2015; 22(6): 423-430.

Barkin RL: The pharmacology of topical analgesic. Postgraduate Medicine. 2013; 125(supp 1): 7-13.

Barkin RL: Nonopioid analgesics for osteoarthritis: Availability of topical NSAIDS. J Pain Palliat Care Pharmacother. 2010; 24(2): 180-181.

Barkin RL, Beckerman M, Blum S, et al.: Should nonsteroidal anti-inflammatory drugs be prescribed to the older adult? Drugs & Aging. 2010; 27(10): 775-789.

Jay GW, Barkin RL: Fibromyalgia (review). Disease-a-Month. 2015; 61(3): 66-111.

Jay GW, Barkin RL: Neuropathtic pain: Etiology, pathophysiology, mechanisms, and evaluations. Disease-a-Month. 2014; 60(1): 6-47.

McCarberg B, Barkin RL, Zaleon C: The management of neuropathic pain with a focus upon older adults (Review). Amer J of Therapeutics. 2012; 19(3): 211-227.

Barkin RL, Barkin SJ, Irving GA, et al.: Management of chronic noncancer pain in depressed patients (Review). Postgraduate Medicine. 2011; 123(5): 143-154.

Barkin RL: Reducing cardiovascular risks of nonsteroidal anti-inflammatory drugs by using topical formulations. Am J Cardiol. 2009; 104(9): 1315.

Barkin RL, Barkin SA: The Role of Venlafaxine and Duloxetine in the Treatment of Depression with Decremental Changes in Somatic Symptoms of Pain, Chronic Pain, and the Pharmacokinetics and Clinical Considerations of Duloxetine Pharmacotherapy. Am Jour Therapeutics. 2005; 12: 431-438.

Leo RJ, Barkin RL: Antidepressant Use in Chronic Pain Management: Is There Evidence of a Role for Duloxetine? Primary Care Companion J Clin Psychiatry. 2003; 5(3): 118-123.

Beebe F, Barkin RL, Barkin, SA: Clinical and Pharmacologic Review of Skeletal Muscle Relaxants for Musculoskeletal Conditions. Am J Therapeutics. 2005; 12(2): 151-171.

Barkin RL: Interview: the need to tailor pain management approaches to individual requirements. Pain Manag. 2012; 2(5): 435–436.

Barkin RL: Tapentadol: A pharmacotherapeutic Focused Brief Review, Pain Medicine Network. The American Academy of Pain Medicine. 2009; 24(1): Fall 2009.